Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies (Tables)

v3.8.0.1
Basis of Presentation and Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

The Company had the following common stock equivalents:

 

    March 31,  
    2018     2017  
Convertible preferred stock, Series A     27,924       26,687  
Convertible preferred stock, Series A-1     17,700       15,746  
Common stock warrants     1,129,925       819,925  
Restricted stock units     126,465       -  
Options     47,870       -  
Total potentially dilutive shares     1,349,884       862,358